Search - tctmd.com

Displaying 321 - 340 of 1897

Sort: Relevancy | Date

Presentation TCT 2015

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Presenter: Frederick Feit, David J. Maron, Sripal Bangalore

October 15, 2015

Presentation TCT 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh

October 15, 2015

Presentation TCT 2015

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Presenter: Jeffrey W. Moses, Erick Schampaert

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

CTO Revascularization: 2015 Update

Presenter: Larry S. Dean, Simon R. Dixon, Mauro Carlino

October 14, 2015

Presentation TCT 2015

For This Patient, I Suggest Hybrid Coronary Revascularization (Lets Split the Difference)

Presenter: John D. Puskas

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

Advertisement

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

CTO Revascularization: 2015 Update

For This Patient, I Suggest Hybrid Coronary Revascularization (Lets Split the Difference)

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content